Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Tavilermide

Copy Product Info
😃Good
Catalog No. T17000Cas No. 263251-78-1
Alias MIM-D3, MIMD3

Tavilermide (MIM-D3) is a selective TrkA agonist, a cyclic mimetic, which can be used to study dry keratoconjunctivitis and dry eye syndrome.

Tavilermide

Tavilermide

Copy Product Info
😃Good
Purity: 98.98%
Catalog No. T17000Alias MIM-D3, MIMD3Cas No. 263251-78-1
Tavilermide (MIM-D3) is a selective TrkA agonist, a cyclic mimetic, which can be used to study dry keratoconjunctivitis and dry eye syndrome.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$199-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.98%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Tavilermide (MIM-D3) is a selective TrkA agonist, a cyclic mimetic, which can be used to study dry keratoconjunctivitis and dry eye syndrome.
In vitro
Tavilermide, a tyrosine kinase TrkA receptor agonist, is a protease-stabilized cyclic peptide mimetic that has been shown to be a partial TrkA receptor agonist for the treatment of dry eye. Tavilermide exhibits activity similar to that of nerve growth factor (NGF), but does not bind to the p75NTR receptor, and enhances the effects of suboptimal concentrations of effects of NGF. [1]
SynonymsMIM-D3, MIMD3
Chemical Properties
Molecular Weight580.54
FormulaC24H32N6O11
Cas No.263251-78-1
SmilesO=C1C=2C(=CC=C(N(=O)=O)C2)OCC[C@@H](C(NCC(O)=O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)N1
Relative Density.1.341 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
NH4OH: 30 mg/mL(51.68 mM), when pH is adjusted with NH4OH. Sonication is recommmended.
H2O: 5 mg/mL (8.61 mM), Sonication is recommended.
Solution Preparation Table
H2O/NH4OH
1mg5mg10mg50mg
1 mM1.7225 mL8.6127 mL17.2253 mL86.1267 mL
5 mM0.3445 mL1.7225 mL3.4451 mL17.2253 mL
NH4OH
1mg5mg10mg50mg
10 mM0.1723 mL0.8613 mL1.7225 mL8.6127 mL
20 mM0.0861 mL0.4306 mL0.8613 mL4.3063 mL
50 mM0.0345 mL0.1723 mL0.3445 mL1.7225 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Tavilermide | purchase Tavilermide | Tavilermide cost | order Tavilermide | Tavilermide chemical structure | Tavilermide in vitro | Tavilermide formula | Tavilermide molecular weight